T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.16B |
| 2 |
GE Aerospace
GE
|
+$1.93B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.62B |
| 4 |
Eli Lilly
LLY
|
+$1.59B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.72B |
| 2 |
Booking.com
BKNG
|
+$2.61B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.62B |
| 4 |
JPMorgan Chase
JPM
|
+$1.43B |
| 5 |
State Street
STT
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.53% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
2001
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $602K | ﹤0.01% |
14,948
+1,818
| +14% | +$93.7K |
|
|
NXGN
2002
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $602K | ﹤0.01% |
39,718
+95
| +0.2% | +$1.63K |
|
2003
Franklin Electric
FELE
$4.69B
| $601K | ﹤0.01% |
14,026
+87
| +0.6% | +$3.77K |
|
|
LHCG
2004
DELISTED
LHC Group LLC
LHCG
| $599K | ﹤0.01% |
6,382
+159
| +3% | +$15.2K |
|
2005
Metallus
MTUS
$890M
| $598K | ﹤0.01% |
68,430
+28,169
| +70% | +$323K |
|
2006
PUT
Deere & Co
DE
$165B
| $597K | ﹤0.01% |
4,000
| – | – |
|
2007
V2X
VVX
$2.54B
| $597K | ﹤0.01% |
27,680
+22
| +0.1% | +$562 |
|
|
BMTC
2008
DELISTED
Bryn Mawr Bank Corp
BMTC
| $597K | ﹤0.01% |
17,369
+36
| +0.2% | +$1.42K |
|
2009
Arrowhead Research
ARWR
$12.1B
| $594K | ﹤0.01% |
47,863
+8,754
| +22% | +$120K |
|
2010
Builders FirstSource
BLDR
$7.91B
| $593K | ﹤0.01% |
54,327
+26,405
| +95% | +$332K |
|
|
GWB
2011
DELISTED
Great Western Bancorp, Inc.
GWB
| $593K | ﹤0.01% |
18,988
+4,010
| +27% | +$146K |
|
|
CXP
2012
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $592K | ﹤0.01% |
30,596
+13,556
| +80% | +$290K |
|
2013
Motorcar Parts of America
MPAA
$235M
| $590K | ﹤0.01% |
35,459
+5,337
| +18% | +$101K |
|
2014
Moelis & Co
MC
$5.19B
| $578K | ﹤0.01% |
+16,803
| New | +$713K |
|
2015
Atlantic Union Bankshares
AUB
$6.1B
| $575K | ﹤0.01% |
20,383
-476,669
| -96% | -$16M |
|
2016
OneSpan
OSPN
$624M
| $574K | ﹤0.01% |
44,326
+25,559
| +136% | +$415K |
|
2017
Cogent Communications
CCOI
$529M
| $573K | ﹤0.01% |
12,666
+76
| +0.6% | +$3.76K |
|
2018
Hain Celestial
HAIN
$54.6M
| $573K | ﹤0.01% |
36,150
-5,871
| -14% | -$131K |
|
|
HEES
2019
DELISTED
H&E Equipment Services
HEES
| $572K | ﹤0.01% |
28,030
+11,158
| +66% | +$273K |
|
2020
TTM Technologies
TTMI
$14.5B
| $572K | ﹤0.01% |
58,777
+12,668
| +27% | +$155K |
|
|
CHMI
2021
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $569K | ﹤0.01% |
32,425
+13,159
| +68% | +$240K |
|
2022
Extreme Networks
EXTR
$3.15B
| $569K | ﹤0.01% |
93,250
-20,686
| -18% | -$120K |
|
|
CSII
2023
DELISTED
Cardiovascular Systems, Inc.
CSII
| $568K | ﹤0.01% |
19,938
+2,858
| +17% | +$90.8K |
|
|
LM
2024
DELISTED
Legg Mason, Inc.
LM
| $561K | ﹤0.01% |
21,998
-21,050
| -49% | -$590K |
|
|
NXTM
2025
DELISTED
NxStage Medical Inc.
NXTM
| $560K | ﹤0.01% |
19,576
+108
| +0.6% | +$3.07K |
|
Similar funds
T. Rowe Price Associates's Q4 2018 Portfolio in Review
As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
- T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
- T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
- T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
- T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.
Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.